Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16785906 | 0.97 | L3MBTL1 (0.41) | NPC1SMN1; SMN2CYP1A2CYP2C19RAB9A | |
| SCHEMBL16716644 | 0.92 | NR1H4 (0.41) | NPC1SMN1; SMN2CYP1A2CYP2C19RAB9A | |
| SCHEMBL16716629 | 0.92 | NR1H4 (0.40) | NPC1SMN1; SMN2CYP1A2CYP2C19RAB9A | |
| SCHEMBL16716622 | 0.86 | MEN1 (0.47) | NPC1SMN1; SMN2RAB9AHSD17B10MAPT | |
| SCHEMBL27391140 | 0.85 | RXRA (0.40) | CYP1A2CYP2C19MAPTMEN1KMT2A | |
| SCHEMBL23697401 | 0.85 | MEN1 (0.44) | NPC1SMN1; SMN2RAB9AMAPTMEN1 | |
| SCHEMBL18878285 | 0.85 | MEN1 (0.44) | NPC1SMN1; SMN2RAB9AMAPTMEN1 | |
| SCHEMBL31664378 | 0.85 | MEN1 (0.44) | NPC1SMN1; SMN2RAB9AMAPTMEN1 | |
| SCHEMBL17151700 | 0.85 | MEN1 (0.44) | NPC1SMN1; SMN2RAB9AMAPTMEN1 | |
| SCHEMBL17887165 | 0.85 | MEN1 (0.44) | NPC1SMN1; SMN2RAB9AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9882146-B2 | Heterocyclic compound and organic electronic element containing same | LG CHEM, LTD. (KR) | 2018-01-30 | — | — | US | disclosed |
| US-9882146-B2 | Heterocyclic compound and organic electronic element containing same | LG CHEM, LTD. (KR) | 2018-01-30 | — | — | US | disclosed |
| US-20160218298-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME | LG CHEM, LTD. (KR) | 2016-07-28 | — | — | US | disclosed |
| US-20160218298-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME | LG CHEM, LTD. (KR) | 2016-07-28 | — | — | US | disclosed |
| US-9391281-B2 | Heterocyclic compound and organic electronic element containing same | LG CHEM, LTD. (KR) | 2016-07-12 | — | — | US | disclosed |
| US-9391281-B2 | Heterocyclic compound and organic electronic element containing same | LG CHEM, LTD. (KR) | 2016-07-12 | — | — | US | disclosed |
| US-20150162543-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME | LG CHEM, LTD. (KR) | 2015-06-11 | — | — | US | disclosed |
| US-20150162543-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME | LG CHEM, LTD. (KR) | 2015-06-11 | — | — | US | disclosed |
| EP-2873667-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME | LG Chem, Ltd. (KR) | 2015-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160218298-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME | ESR1, ERCC1, NFE2L2 | NPC1 2492/4885SMN1; SMN2 563/4885CYP1A2 649/4885 |
| US-20150162543-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME | ESR1, ERCC1, NFE2L2 | NPC1 2492/4885SMN1; SMN2 563/4885CYP1A2 649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.